De-implementation of low-value bronchiolitis practices showed sustained adherence two years post-trial in a cluster RCT follow-up
Doctors Stick to Better Bronchiolitis Care—2 Years Later
This cluster randomised controlled trial (cRCT) follow-up study assessed the sustainability of de-implementing low-value bronchiolitis pract…
It’s 2 a.m. in a busy children’s hospital.
Single-center retrospective study associates ferritin and eosinophil levels with acute asthma exacerbation in children
High Iron Levels Signal Worse Asthma Attacks in Kids
This single-center retrospective study examined 120 children with asthma to identify markers associated with acute exacerbation.
Checking iron levels alongside standard asthma markers could help doctors predict dangerous flare-ups sooner.
Benralizumab reduces asthma exacerbations in severe eosinophilic asthma patients over 24 weeks
New Asthma Shot May Cut Severe Attacks to Zero
This prospective, single-arm, multicenter, phase IV study evaluated benralizumab in 138 benralizumab-naïve adults (18–75 years) with severe …
A new injection appears safe and effective at reducing severe asthma attacks in adults.
Meta-analysis identifies DNA methylation markers linked to asthma exacerbations in diverse pediatric populations
Blood Markers May Predict Severe Asthma Attacks in Kids
This meta-analysis synthesizes data from African American and Latino pediatric populations and ethnically diverse participants to evaluate D…
New research spots chemical changes in blood that signal when asthma might get dangerous.
Combined digital and paper audit feedback did not improve asthma prescribing versus digital-only in primary care
Paper Letters Add Nothing to Digital Asthma Care Plans
This cluster randomized controlled trial in 270 primary care practices in West Yorkshire compared combined digital and paper audit and feedb…
Sending printed reports to doctors does not improve asthma care more than sending emails.
Polygenic risk scores improve identification of rare variant carriers in idiopathic pulmonary fibrosis patients
Can a genetic test help spot hidden lung disease risks in pulmonary fibrosis patients?
This observational cohort study of 888 IPF patients from the PFF-PR and 472 from the UK PROFILE cohort found that polygenic risk scores (PRS…
A genetic test helps doctors spot hidden disease risks in lung patients by finding rare gene variants that standard history alone might miss…
Review of UK Biobank data identifies plasma protein mediators in cardiometabolic disease progression
New Blood Test Clues Could Predict Diabetes Complications Years Earlier
This observational review analyzes UK Biobank data from 53,030 participants to evaluate plasma proteins as mediators in secondary disease de…
A new blood test spots specific proteins that warn of heart, kidney, and brain problems years before they happen in people with diabetes or …
Observational biobank study compares phenomic and social determinants for disease risk prediction
Your Genes Aren’t Your Destiny: How Your Neighborhood Changes Your Risk
This research article from UK Biobank and other cohorts evaluates phenome-derived polygenic scores and social determinants for predicting as…
Your neighborhood and lifestyle can reshape your genetic risk for diseases like asthma and heart disease, offering a clearer health picture …
Systematic review and meta-analysis of pulmonary telerehabilitation versus center-based care in COPD
Remote Breathing Rehab Works Just as Well as In-Clinic Visits for COPD
This systematic review and meta-analysis synthesized evidence on pulmonary telerehabilitation (Tele-PR) versus center-based rehabilitation (…
Remote breathing rehab matches in-clinic visits for COPD patients, offering a flexible option for those who struggle to travel for care.
Systematic review finds high relapse rates in pulmonary sarcoidosis across diverse study designs
Pulmonary Sarcoidosis Relapse: 40% of Patients Face Recurrence, New Study Reveals
This systematic review and meta-analysis evaluated the prevalence of relapse in patients with pulmonary sarcoidosis.
About 4 in 10 people with pulmonary sarcoidosis see their disease return after treatment, with higher risks for Black patients and those wit…
Multicomponent breathing and exercise program improves breathlessness mastery in moderate to severe COPD
New Breathing Program Helps COPD Patients Regain Control Over Daily Life
In this randomized controlled trial of 113 patients with moderate to severe COPD and disabling breathlessness, an 8-week multicomponent inte…
An 8-week coaching program helps severe COPD patients control breathlessness and reduce daily discomfort without relying only on medication.
Narrative review examines lung microbiome and mucosal IgA in chronic inflammatory lung diseases
Your Lungs Have Their Own Microbiome — and It Affects Your Immune Defenses
This narrative review explores the interplay between the lung microbiome and mucosal immunoglobulin A system in chronic inflammatory lung di…
The lung's microbiome and immune protein IgA work together to protect health, and their breakdown drives chronic lung diseases like asthma a…